Wilson Sonsini Goodrich & Rosati is pleased to sponsor LaunchBio’s Larger Than Life Science, Critical Cash-How to Raise Non-Dilutive Funding. Biotech and life science startups often rely on government industry grants, including the Small Business Innovation Research (SBIR) and Technology Transfer (STTR) programs, which are designed to enable the commercialization of cutting-edge technologies. Other sources of non-dilutive funding include foundations, industry partnerships, and venture debt.  While these can be important sources of cash, non-dilutive funds are not “free” and can have some unintended consequences and costs. A variety of perspectives—entrepreneur, investor, entrepreneurial support organization and legal expert—will be presented on how to secure and deploy this type of “critical cash.”